Type
Internal restructuring
Country
Germany
Region
Location of affected unit(s)
Karlsruhe and Nuremberg
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

760 jobs
Number of planned job losses
Job loss
Announcement Date
23 January 2007
Employment effect (start)
24 January 2007
Foreseen end date
31 December 2008

Description

The US-based pharmaceutical company Pfizer announced on 23 January 2007 its plans to cut a total of 760 jobs of its 5,200 jobs in Germany. 320 jobs will be cut in the German headquarter in Karlsruhe an another 440 jobs will be affected by the planned sale of the company's subsidiary Arzneimittelwerk Heumann PCS in Nuremberg. Other sites of Pfizer in Germany will not be affected by job cutting measures. Pfizer is reported to face substantial reductions in overall turnover and profits as a number of its products are to lose their patent protection in the forthcoming years. The company wants to save 5 billion USD in costs world-wide and is said to cut a total of 10,000 jobs.


Sources

  • 24 January 2007: Financial Times Deutschland

Citation

Eurofound (2007), Pfizer, Internal restructuring in Germany, factsheet number 64836, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/64836.